Novavax (NasdaqGS:NVAX) recently amended its collaboration agreement with Takeda, enhancing its revenue potential through a new upfront payment structure and future royalties. These developments, ...

Novavax, Inc. (NVAX) said it has updated the terms of the collaboration and licensing agreement with Takeda. The company noted that the improved financial terms of the amended ...

A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.

Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...

Health experts raise concerns about the rise in vaccine skepticism and hesitancy as a bill criminalizing certain vaccines circulates in the state Legislature. A group of Minnesota House Republicans ...

Dr. Vinay Prasad succeeds Dr. Peter Marks, who left the role of leader of the FDA’s Center for Biologics Evaluation and ...

The HHS will begin to require placebo-controlled trials for all new vaccines, which will radically alter the testing process.

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...

In late April, Summit Therapeutics revealed interim OS data from HARMONi-2 for its PD-1/VEGF bispecific antibody, ivonescimab ...

(CTN News) – The Food and Drug Administration (FDA) has elected to appoint a new director for the Center for Biologics ...